CS logo
small CS logo
Shiga University of Medical Science Hospital

Otsu, Shiga, Japan
University hospital in Kusatsu
Setatsukinowacho, Otsu, Shiga 520-2192

About Shiga University of Medical Science Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Shiga University
11
Pfizer
6
Shire
5
Hoffmann-La Roche
4
Boehringer Ingelheim
3
Galapagos NV
3
Janssen Pharmaceutical K.K.
3
Takeda
3
Chugai Pharmaceutical
2
Janssen Research & Development, LLC
2
Mitsubishi Tanabe Pharma America Inc.
2
Total Rows: 25

Clinical Trials at Shiga University of Medical Science Hospital


During the past decade, Shiga University of Medical Science Hospital conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 16 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 13 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11667777886666110011111100115577Started TrialsCompleted Trails201520162017201820192020202120220246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan
2002-12-01
2008-09-01
Completed
150
Rationale and Design for Shiga Microalbuminuria Reduction Trial
2003-12-01
2006-06-01
Unknown status
160
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
2005-03-01
2016-02-01
Completed
255
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer
2005-07-01
2021-12-13
Completed
6,927
Shiga Progression of Diabetes, Nephropathy and Retinopathy
2008-03-01
2011-11-01
Unknown status
400
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer
2010-02-01
2019-03-01
Completed
18
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer
2010-02-01
2019-03-01
Completed
9
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer
2010-02-01
2019-03-01
Completed
9

Rows per page:

1–59 of 59

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Shiga University of Medical Science Hospital" #1 sponsor was "Shiga University" with 11 trials, followed by "Pfizer" with 6 trials sponsored, "Shire" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Shiga University of Medical Science Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Human Genome Center, Institute of Medical Science, University of Tokyo" with 3 trials as a collaborator, "Tokyo University" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Ako City Hospital" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.
Created with Highcharts 11.1.0Top Leading SponsorsShiga University: 11Shiga University: 11Pfizer: 6Pfizer: 6Shire: 5Shire: 5Hoffmann-La Roche: 4Hoffmann-La Roche: 4Boehringer Ingelheim: 3Boehringer Ingelheim: 3Galapagos NV: 3Galapagos NV: 3Janssen Pharmaceutical K.K.: 3Janssen Pharmaceutical K.K.: 3Takeda: 3Takeda: 3Chugai Pharmaceutical: 2Chugai Pharmaceutical: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2

Created with Highcharts 11.1.0Top CollaboratorsGilead Sciences: 3Gilead Sciences: 3Human GenomeCenter, Institute ofMedical Science,University of Tokyo: 3Human GenomeCenter, Institute ofMedical Science,University of Tokyo: 3Tokyo University: 3Tokyo University: 3Japan Lung Cancer Society: 2Japan Lung Cancer Society: 2Ako City Hospital: 1Ako City Hospital: 1Arena is a whollyowned subsidiary ofPfizer: 1Arena is a whollyowned subsidiary ofPfizer: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Brigham and Women'sHospital: 1Brigham and Women'sHospital: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Galapagos NV: 1Galapagos NV: 1

Clinical Trials Conditions at Shiga University of Medical Science Hospital


According to Clinical.Site data, the most researched conditions in "Shiga University of Medical Science Hospital" are "Ulcerative Colitis" (12 trials), "Crohn's Disease" (7 trials), "Non-small Cell Lung Cancer" (5 trials), "Hypertension" (3 trials) and "ALS" (2 trials). Many other conditions were trialed in "Shiga University of Medical Science Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Shiga University of Medical Science Hospital


Most popular intervention types in "Shiga University of Medical Science Hospital" are "Drug" (44 trials), "Other" (11 trials), "Biological" (7 trials), "Procedure" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Filgotinib" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Shiga University of Medical Science Hospital


The vast majority of trials in "Shiga University of Medical Science Hospital" are 57 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Shiga University of Medical Science Hospital


Currently, there are NaN active trials in "Shiga University of Medical Science Hospital". undefined are not yet recruiting, 6 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in Shiga University of Medical Science Hospital, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Shiga University of Medical Science Hospital, 6 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 32Phase 3: 32Phase 2: 12Phase 2: 12Phase 1: 6Phase 1: 6Phase 4: 4Phase 4: 4Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 28Completed: 28Active, not recruiting: 15Active, not recruiting: 15Recruiting: 6Recruiting: 6Terminated: 5Terminated: 5Unknown status: 4Unknown status: 4Enrolling by invitation: 1Enrolling by invitation: 1